Tumor-associated soluble uPAR-directed endothelial cell motility and tumor angiogenesis.
about
Soluble Urokinase Receptor Is Released Selectively by Glioblastoma Cells That Express Epidermal Growth Factor Receptor Variant III and Promotes Tumor Cell Migration and Invasion.Lipid rafts: integrated platforms for vascular organization offering therapeutic opportunities.uPAR promotes tumor-like biologic behaviors of fibroblast-like synoviocytes through PI3K/Akt signaling pathway in patients with rheumatoid arthritis.Caveolin-1-dependent and -independent uPAR signaling pathways contribute to ganglioside GT1b induced early apoptosis in A549 lung cancer cells.Differential uPAR recruitment in caveolar-lipid rafts by GM1 and GM3 gangliosides regulates endothelial progenitor cells angiogenesis.Ulinastatin Inhibits Osteoclastogenesis and Suppresses Ovariectomy-Induced Bone Loss by Downregulating uPAR
P2860
Tumor-associated soluble uPAR-directed endothelial cell motility and tumor angiogenesis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Tumor-associated soluble uPAR-directed endothelial cell motility and tumor angiogenesis.
@en
Tumor-associated soluble uPAR-directed endothelial cell motility and tumor angiogenesis.
@nl
type
label
Tumor-associated soluble uPAR-directed endothelial cell motility and tumor angiogenesis.
@en
Tumor-associated soluble uPAR-directed endothelial cell motility and tumor angiogenesis.
@nl
prefLabel
Tumor-associated soluble uPAR-directed endothelial cell motility and tumor angiogenesis.
@en
Tumor-associated soluble uPAR-directed endothelial cell motility and tumor angiogenesis.
@nl
P2093
P2860
P356
P1433
P1476
Tumor-associated soluble uPAR-directed endothelial cell motility and tumor angiogenesis.
@en
P2093
P2860
P2888
P356
10.1038/ONCSIS.2013.19
P577
2013-06-24T00:00:00Z